Teenage and Young Adult Cancer

Teenagers and Young Adults with Cancer Research Grants offered for Nursing and Allied Health Professional research

Addressing any of the priorities:  Research bursaries advertised in January 2023.

Supporting the complete care of children and young people with life-threatening or life-shortening conditions: a mixed-method study of pastoral, spiritual and religious needs and support, and the role of chaplaincy services (The SPARK Project)

Addressing priority 5:  NIHR research in progress

This study aim to gather evidence the NHS and children's hospices can use to inform the provision and practices of chaplaincy services for children facing end of life, and their parents. It will also establish if families have the same access to chaplaincy services as adult patients, and whether certain groups are more likely to have unmet needs for spiritual care and support.

End of Life Care for Infants, Children and Young People: a mixed methods evaluation of current practice in the United Kingdom

Addressing priority 5:  NIHR research in progress

This study will increase understanding about the different ways in which end of life care is provided for children and young people, and examine how these different models of providing end of life care impact on children and their families. 

CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia): A randomised trial to assess the use of ciprofloxacin prophylaxis to prevent bacterial infection in children treated on the induction phase of the ALLTogether-1 treatment protocol

Addressing key priorities from the PSP:  NIHR research in progress

Acute Lymphoblastic Leukaemia (ALL) is one of the commonest forms of childhood cancer. Treatment has improved and survival rates are now high. ALL treatment involves chemotherapy which reduces the child's ability to fight infections. Infection is now one of the commonest causes of death in children with ALL, and this is most likely to happen in the first five weeks of treatment called Induction . In children with other types of leukaemia and in children whose ALL has come back after treatment (relapsed), it has been shown that giving a daily, low dose of antibiotics every day can reduce the risk of infection by about a half, but nobody has tested it in children the first time they have treatment for ALL. This study will work alongside the ALLTogether-1 study in the UK and will aim to answer the question "Does adding a daily, low-dose antibiotic (called ciprofloxacin) during the first part of chemotherapy treatment (induction) reduce the risk of infection in children, age 1-17 years old, with new ALL?"

Teenagers and Young Adults with Cancer Late Effects Research Grants

Addressing priorities 1, 2 and 9 from the PSP:  Research funding grant round opened in December 2021